Statements of Operations and Comprehensive Loss - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021
Total revenue, net	$ 4,812	$ 8,193
Operating expenses:
Cost of product sold	8,391	0
Research and development	70,831	157,591
Selling, general and administrative	40,729	42,418
Total operating expenses	119,951	200,009
Loss from operations	(115,139)	(191,816)
Other income (expense), net	2,127	(220)
Net loss and comprehensive loss	$ (113,012)	$ (192,036)
Net loss per share - basic	$ (4.24)	$ (8.48)
Net loss per share - diluted	$ (4.24)	$ (8.48)
Weighted-average number of shares of common stock outstanding - basic	26,633,241	22,655,339
Weighted-average number of shares of common stock outstanding - diluted	26,633,241	22,655,339
Grant
Revenue	$ 1,160	$ 8,193
Product revenue, net
Revenue	$ 3,652	$ 0